Free Trial

Globus Medical Q3 2024 Earnings Report

Globus Medical logo
$90.84 +0.37 (+0.40%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Globus Medical EPS Results

Actual EPS
$0.83
Consensus EPS
$0.65
Beat/Miss
Beat by +$0.18
One Year Ago EPS
$0.57

Globus Medical Revenue Results

Actual Revenue
$625.71 million
Expected Revenue
$604.69 million
Beat/Miss
Beat by +$21.02 million
YoY Revenue Growth
+63.10%

Globus Medical Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Globus Medical Earnings Headlines

Brokers Set Expectations for Globus Medical FY2024 Earnings
liberals FOOLED by Elon’s shocking surprise
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…
Globus Medical (NYSE:GMED) Price Target Raised to $101.00
See More Globus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Globus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your email.

About Globus Medical

Globus Medical (NYSE:GMED), a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

View Globus Medical Profile

More Earnings Resources from MarketBeat